Senthil Vel Sundaram

Insider Reports History

Location
Waltham, MA
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Senthil Sundaram
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Senthil Vel Sundaram:

Company Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 9,770 $36,931 $3.78 31 May 2023 Direct

Insider Reports Filed by Senthil Vel Sundaram

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TERN Terns Pharmaceuticals, Inc. 31 May 2023 1 +$2,977 4 Chief Executive Officer, Director 02 Jun 2023, 17:03
TERN Terns Pharmaceuticals, Inc. 01 Feb 2023 2 +$4.23 4 Chief Executive Officer, Director 03 Feb 2023, 17:00
TERN Terns Pharmaceuticals, Inc. 31 May 2022 1 +$11,254 4 Chief Executive Officer, Director 08 Jun 2022, 21:27
TERN Terns Pharmaceuticals, Inc. 26 Jan 2022 1 $0 4 Chief Executive Officer, Director 28 Jan 2022, 20:00
TERN Terns Pharmaceuticals, Inc. 28 Sep 2021 1 $0 4 Chief Executive Officer, Director 30 Sep 2021, 21:13
/report/000120919121057632-sundaram-senthil-vel-2021-09-24 Social Capital Suvretta Holdings Corp. I 24 Sep 2021 0 $0 3 Director 24 Sep 2021, 16:48